HBIO
Price
$0.47
Change
-$0.02 (-4.08%)
Updated
Sep 3 closing price
Capitalization
21.01M
63 days until earnings call
SGHT
Price
$3.80
Change
-$0.07 (-1.81%)
Updated
Sep 3 closing price
Capitalization
199M
63 days until earnings call
Interact to see
Advertisement

HBIO vs SGHT

Header iconHBIO vs SGHT Comparison
Open Charts HBIO vs SGHTBanner chart's image
Harvard Bioscience
Price$0.47
Change-$0.02 (-4.08%)
Volume$381.36K
Capitalization21.01M
Sight Sciences
Price$3.80
Change-$0.07 (-1.81%)
Volume$95.47K
Capitalization199M
HBIO vs SGHT Comparison Chart in %
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGHT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HBIO vs. SGHT commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a StrongBuy and SGHT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (HBIO: $0.47 vs. SGHT: $3.80)
Brand notoriety: HBIO and SGHT are both not notable
HBIO represents the Pharmaceuticals: Other, while SGHT is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: HBIO: 49% vs. SGHT: 80%
Market capitalization -- HBIO: $21.01M vs. SGHT: $199M
HBIO [@Pharmaceuticals: Other] is valued at $21.01M. SGHT’s [@Medical/Nursing Services] market capitalization is $199M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.15B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.05B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.75B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green whileSGHT’s FA Score has 0 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • SGHT’s FA Score: 0 green, 5 red.
According to our system of comparison, SGHT is a better buy in the long-term than HBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 2 TA indicator(s) are bullish while SGHT’s TA Score has 4 bullish TA indicator(s).

  • HBIO’s TA Score: 2 bullish, 5 bearish.
  • SGHT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SGHT is a better buy in the short-term than HBIO.

Price Growth

HBIO (@Pharmaceuticals: Other) experienced а -11.25% price change this week, while SGHT (@Medical/Nursing Services) price change was -10.17% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.09%. For the same industry, the average monthly price growth was +6.96%, and the average quarterly price growth was +33.57%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.08%. For the same industry, the average monthly price growth was +1.73%, and the average quarterly price growth was +23.90%.

Reported Earning Dates

HBIO is expected to report earnings on Nov 06, 2025.

SGHT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.09% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.08% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGHT($199M) has a higher market cap than HBIO($21M). SGHT YTD gains are higher at: 4.396 vs. HBIO (-77.536). SGHT has higher annual earnings (EBITDA): -43.26M vs. HBIO (-46.8M). SGHT has more cash in the bank: 102M vs. HBIO (7.44M). SGHT has less debt than HBIO: SGHT (40.6M) vs HBIO (43.3M). HBIO has higher revenues than SGHT: HBIO (88.8M) vs SGHT (76.3M).
HBIOSGHTHBIO / SGHT
Capitalization21M199M11%
EBITDA-46.8M-43.26M108%
Gain YTD-77.5364.396-1,764%
P/E RatioN/AN/A-
Revenue88.8M76.3M116%
Total Cash7.44M102M7%
Total Debt43.3M40.6M107%
FUNDAMENTALS RATINGS
HBIO: Fundamental Ratings
HBIO
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HBIOSGHT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
73%
Bullish Trend 14 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGHT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIQT2.110.20
+10.45%
LiqTech International
PCVX32.100.54
+1.71%
Vaxcyte
TRVI7.15-0.12
-1.65%
Trevi Therapeutics
EA167.86-3.59
-2.09%
Electronic Arts
SANG5.74-0.34
-5.59%
Sangoma Technologies Corp

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with IRMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then IRMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
-3.11%
IRMD - HBIO
51%
Loosely correlated
-1.43%
SGHT - HBIO
39%
Loosely correlated
-1.81%
A - HBIO
38%
Loosely correlated
+0.01%
TMO - HBIO
35%
Loosely correlated
-0.61%
MTD - HBIO
35%
Loosely correlated
-0.58%
More

SGHT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGHT has been closely correlated with JNDOF. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if SGHT jumps, then JNDOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGHT
1D Price
Change %
SGHT100%
-1.81%
JNDOF - SGHT
75%
Closely correlated
N/A
TWST - SGHT
45%
Loosely correlated
-0.91%
BLFS - SGHT
43%
Loosely correlated
-1.18%
HBIO - SGHT
43%
Loosely correlated
-3.11%
SMTI - SGHT
42%
Loosely correlated
-3.23%
More